The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
Lutz, M. B., Kukutsch, N., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,966
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Dendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869
Therapeutic vaccines for cancer: an overview of clinical trials
Melero, I., Gaudernack, G., Gerritsen, W., Huber, C., Parmiani, G., Scholl, S., Thatcher, N., Wagstaff, J., Zielinski, C., Faulkner, I., et al. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.111 · Cited by 776
Sixt, M., Kanazawa, N., Selg, M., Samson, T., Roos, G., Reinhardt, D. P., Pabst, R., Lutz, M. B., & Sorokin, L. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.013 · Cited by 747
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T., & Falo, L. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.283 · Cited by 717
Carroll, E. C., Jin, L., Mori, A., Muñoz-Wolf, N., Oleszycka, E., Moran, H. B. T., Mansouri, S., McEntee, C. P., Lambe, E., Agger, E. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.004 · Cited by 596
Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?
Kambayashi, T., & Laufer, T. M. (2014) · Nature Reviews Immunology · doi:10.1038/nri3754 · Cited by 495
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.005 · Cited by 406
Engering, A. J., Cella, M., Fluitsma, D., Brockhaus, M., Hoefsmit, E. C. M., Lanzavecchia, A., & Pieters, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270941 · Cited by 400
Chitosan-based drug nanocarriers: Where do we stand?
Garcia-Fuentes, M., & Alonso, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.017 · Cited by 353
Moon, J. J., Suh, H., Li, A. V., Ockenhouse, C. F., Yadava, A., & Irvine, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112648109 · Cited by 312
Dendritic cells: On the move from bench to bedside
Nestle, F. O., Banchereau, J., & Hart, D. (2001) · Nature Medicine · doi:10.1038/89863 · Cited by 287
Jäger, E., Ringhoffer, M., Karbach, J., Arand, M., Oesch, F., & Knuth, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960516)66:4<470::aid-ijc10>3.0.co;2-c · Cited by 278
Rosalia, R. A., Cruz, L. J., van Duikeren, S., Tromp, A. T., Silva, A. L., Jiskoot, W., de Gruijl, T., Löwik, C., Oostendorp, J., van der Burg, S. H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.053 · Cited by 269
Targeting Dendritic Cells with Antigen-Containing Liposomes
van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., & Altin, J. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0138 · Cited by 256
Chiang, C. L.-L., Benencia, F., & Coukos, G. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.02.004 · Cited by 247
Rao, Q., Zuo, B., Lu, Z., Gao, X., You, A., Wu, C., Du, Z., & Yin, H. (2016) · Hepatology · doi:10.1002/hep.28549 · Cited by 246
Kwon, Y. J., James, E., Shastri, N., & Fréchet, J. M. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509541102 · Cited by 201
Antigen presentation by dendritic cells in vivo
Segura, E., & Villadangos, J. A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.03.011 · Cited by 168
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
Coffelt, S. B., & de Visser, K. E. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.006 · Cited by 161
Kandalaft, L. E., Powell, Jr., Chiang, C. L., Tanyi, J., Kim, S., Bosch, M., Montone, K., Mick, R., Levine, B. L., Torigian, D. A., et al. (2013) · OncoImmunology · doi:10.4161/onci.22664 · Cited by 159
Qian, Y., Jin, H., Qiao, S., Dai, Y., Huang, C., Lu, L., Luo, Q., & Zhang, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.008 · Cited by 159
Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling
Zhang, Y., Tang, K., Zhang, Y., Ma, R., Ma, J., Li, Y., Luo, S., Liang, X., Ji, T., Gu, Z., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0177 · Cited by 156
Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
Sondak, V. K., & Sosman, J. A. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.004 · Cited by 137
Engineered materials for cancer immunotherapy
Cheung, A. S., & Mooney, D. J. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.007 · Cited by 111
Guo, H. B., Lai, Q., Wang, W., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.025 · Cited by 107
Self-citationXia, X., Mai, J., Xu, R., Perez, J. E. T., Guevara, M. L., Shen, Q., Mu, C., Tung, H.-Y., Corry, D. B., Evans, S. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.009 · Cited by 103
Self-citationSolbrig, C., Saucier-Sawyer, J. K., Cody, V., Saltzman, W. M., & Hanlon, D. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060107e · Cited by 94
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives
Milani, A., Sangiolo, D., Montemurro, F., Aglietta, M., & Valabrega, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt133 · Cited by 83
Thomann, J.-S., Heurtault, B., Weidner, S., Brayé, M., Beyrath, J., Fournel, S., Schuber, F., & Frisch, B. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.015 · Cited by 81
Garu, A., Moku, G., Gulla, S. K., & Chaudhuri, A. (2015) · Molecular Therapy · doi:10.1038/mt.2015.215 · Cited by 74
Rahimian, S., Kleinovink, J. W., Fransen, M. F., Mezzanotte, L., Gold, H., Wisse, P., Overkleeft, H. S., Amidi, M., Jiskoot, W., Löwik, C. W. G. M., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.043 · Cited by 67
The unfulfilled promise of melanoma vaccines.
Livingston, P. O. (2001) · PubMed · Cited by 40
Kosaka, N., Mitsunaga, M., Bhattacharyya, S., Miller, S. C., Choyke, P. L., & Kobayashi, H. (2010) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.395 · Cited by 36
Maharjan, S., Singh, B., Jiang, T., Yoon, S.-Y., Li, H.-S., Kim, G., Gu, M. J., Kim, S. J., Park, O.-J., Han, S. H., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.043 · Cited by 33
Pulsing Dendritic Cells with Whole Tumor Cell Lysates
Alaniz, L. D., Rizzo, M., & Mazzolini, G. D. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0345-0_3 · Cited by 31
Cited by
Chitosan: Structural modification, biological activity and application
Wang, W., Xue, C., & Mao, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.042 · Cited by 647
Self-citationMultifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Chitosan-Based Nanomaterials for Drug Delivery
Li, J., Cai, C., Li, J., Li, J., Li, J., Sun, T., Wang, L., Wu, H., & Yu, G. (2018) · Molecules · doi:10.3390/molecules23102661 · Cited by 481
Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery
Aibani, N., Rai, R., Patel, P., Cuddihy, G., & Wasan, E. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101686 · Cited by 419
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Self-citation
Metadata
- Authors
- Shi, G.-N., Zhang, C.-N., Xu, R., Niu, J.-F., Song, H.-J., Zhang, X.-Y., Wang, W.-W., Wang, Y.-M., Li, C., Wei, X.-Q., & Kong, D.-L.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 113
- Pages
- 191-202
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2543232797
- Cited by
- 299
- References
- 45
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.